A citation-based method for searching scientific literature

Emad A Rakha, Ian O Ellis. Semin Diagn Pathol 2010
Times Cited: 86







List of co-cited articles
559 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.
Bernhard C Pestalozzi, David Zahrieh, Elizabeth Mallon, Barry A Gusterson, Karen N Price, Richard D Gelber, Stig B Holmberg, Jurij Lindtner, Raymond Snyder, Beat Thürlimann,[...]. J Clin Oncol 2008
275
36

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.
Grazia Arpino, Valerie J Bardou, Gary M Clark, Richard M Elledge. Breast Cancer Res 2004
512
36

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
Giovanni Ciriello, Michael L Gatza, Andrew H Beck, Matthew D Wilkerson, Suhn K Rhie, Alessandro Pastore, Hailei Zhang, Michael McLellan, Christina Yau, Cyriac Kandoth,[...]. Cell 2015
31

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.
Emad A Rakha, Maysa E El-Sayed, Desmond G Powe, Andrew R Green, Hany Habashy, Matthew J Grainge, John F R Robertson, Roger Blamey, Julia Gee, Robert I Nicholson,[...]. Eur J Cancer 2008
162
27

Invasive lobular breast cancer: subtypes and outcome.
Monica Iorfida, Eugenio Maiorano, Enrico Orvieto, Patrick Maisonneuve, Luca Bottiglieri, Nicole Rotmensz, Emilia Montagna, Silvia Dellapasqua, Paolo Veronesi, Viviana Galimberti,[...]. Breast Cancer Res Treat 2012
96
27

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes.
Massimo Cristofanilli, Ana Gonzalez-Angulo, Nour Sneige, Shu-Wan Kau, Kristine Broglio, Richard L Theriault, Vicente Valero, Aman U Buzdar, Henry Kuerer, Thomas A Buchholz,[...]. J Clin Oncol 2005
268
25

Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics.
Amy E McCart Reed, Jamie R Kutasovic, Sunil R Lakhani, Peter T Simpson. Breast Cancer Res 2015
171
23

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas.
Y Delpech, C Coutant, L Hsu, E Barranger, T Iwamoto, C H Barcenas, G N Hortobagyi, R Rouzier, F J Esteva, L Pusztai. Br J Cancer 2013
57
29

Genomic Characterization of Primary Invasive Lobular Breast Cancer.
Christine Desmedt, Gabriele Zoppoli, Gunes Gundem, Giancarlo Pruneri, Denis Larsimont, Marco Fornili, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent,[...]. J Clin Oncol 2016
176
19

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
18

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.
Otto Metzger Filho, Anita Giobbie-Hurder, Elizabeth Mallon, Barry Gusterson, Giuseppe Viale, Eric P Winer, Beat Thürlimann, Richard D Gelber, Marco Colleoni, Bent Ejlertsen,[...]. J Clin Oncol 2015
84
19


A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
17


Trends in incidence rates of invasive lobular and ductal breast carcinoma.
Christopher I Li, Benjamin O Anderson, Janet R Daling, Roger E Moe. JAMA 2003
344
16

Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast.
Emad A Rakha, Maysa E El-Sayed, Sindhu Menon, Andrew R Green, Andrew H S Lee, Ian O Ellis. Breast Cancer Res Treat 2008
82
17

Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma.
Sibylle Loibl, Cristina Volz, Christine Mau, Jens-Uwe Blohmer, Serban D Costa, Holger Eidtmann, Peter A Fasching, Bernd Gerber, Claus Hanusch, Christian Jackisch,[...]. Breast Cancer Res Treat 2014
67
20

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution.
M Tubiana-Hulin, D Stevens, S Lasry, J M Guinebretière, L Bouita, C Cohen-Solal, P Cherel, J Rouëssé. Ann Oncol 2006
126
15

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
Esther H Lips, Rita A Mukhtar, Christina Yau, Jorma J de Ronde, Chad Livasy, Lisa A Carey, Claudette E Loo, Marie-Jeanne T F D Vrancken-Peeters, Gabe S Sonke, Donald A Berry,[...]. Breast Cancer Res Treat 2012
65
20

Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer.
W Truin, A C Voogd, G Vreugdenhil, M van der Heiden-van der Loo, S Siesling, R M Roumen. Ann Oncol 2012
35
37

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
12

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas.
P T Simpson, J S Reis-Filho, M B K Lambros, C Jones, D Steele, A Mackay, M Iravani, K Fenwick, T Dexter, A Jones,[...]. J Pathol 2008
105
12

Aberrant expression of E-cadherin in lobular carcinomas of the breast.
Leonard Da Silva, Suzanne Parry, Lynne Reid, Patricia Keith, Nic Waddell, Myriam Kossai, Catherine Clarke, Sunil R Lakhani, Peter T Simpson. Am J Surg Pathol 2008
105
12

The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile.
M-C Mathieu, R Rouzier, A Llombart-Cussac, L Sideris, S Koscielny, J P Travagli, G Contesso, S Delaloge, M Spielmann. Eur J Cancer 2004
120
12

Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response.
Matthew J Sikora, Kristine L Cooper, Amir Bahreini, Soumya Luthra, Guoying Wang, Uma R Chandran, Nancy E Davidson, David J Dabbs, Alana L Welm, Steffi Oesterreich. Cancer Res 2014
89
12

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
W Truin, G Vugts, R M H Roumen, A J G Maaskant-Braat, G A P Nieuwenhuijzen, M van der Heiden-van der Loo, V C G Tjan-Heijnen, A C Voogd. Ann Surg Oncol 2016
47
23

Invasive lobular carcinoma of the breast: incidence and variants.
V Martinez, J G Azzopardi. Histopathology 1979
234
11


Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes.
Nabil Wasif, Melinda A Maggard, Clifford Y Ko, Armando E Giuliano. Ann Surg Oncol 2010
122
11

Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns.
X Sastre-Garau, M Jouve, B Asselain, A Vincent-Salomon, P Beuzeboc, T Dorval, J C Durand, A Fourquet, P Pouillart. Cancer 1996
282
11

Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Schelomo Marmor, Jane Yuet Ching Hui, Jing Li Huang, Scott Kizy, Heather Beckwith, Anne H Blaes, Natasha M Rueth, Todd M Tuttle. Cancer 2017
35
28

Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
10

Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast.
Emad A Rakha, Arjun Patel, Des G Powe, Ahmed Benhasouna, Andrew R Green, Maryou B Lambros, Jorge S Reis-Filho, Ian O Ellis. Am J Surg Pathol 2010
86
10

Wide metastatic spreading in infiltrating lobular carcinoma of the breast.
S Ferlicot, A Vincent-Salomon, J Médioni, P Genin, C Rosty, B Sigal-Zafrani, P Fréneaux, M Jouve, J-P Thiery, X Sastre-Garau. Eur J Cancer 2004
124
10


Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trial.
Otto Metzger-Filho, Marion Procter, Evandro de Azambuja, Brian Leyland-Jones, Richard D Gelber, Mitchell Dowsett, Sherene Loi, Kamal S Saini, David Cameron, Michael Untch,[...]. J Clin Oncol 2013
25
36

Lobular breast cancer: Clinical, molecular and morphological characteristics.
Matthias Christgen, Doris Steinemann, Elna Kühnle, Florian Länger, Oleg Gluz, Nadia Harbeck, Hans Kreipe. Pathol Res Pract 2016
78
11

Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Yayoi Adachi, Junko Ishiguro, Haruru Kotani, Tomoka Hisada, Mari Ichikawa, Naomi Gondo, Akiyo Yoshimura, Naoto Kondo, Masaya Hattori, Masataka Sawaki,[...]. BMC Cancer 2016
46
19

Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
Zheling Chen, Jiao Yang, Shuting Li, Meng Lv, Yanwei Shen, Biyuan Wang, Pan Li, Min Yi, Xiao'ai Zhao, Lingxiao Zhang,[...]. PLoS One 2017
73
12

High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.
Tarek M A Abdel-Fatah, Desmond G Powe, Zsolt Hodi, Andrew H S Lee, Jorge S Reis-Filho, Ian O Ellis. Am J Surg Pathol 2007
171
9

Refinement of breast cancer classification by molecular characterization of histological special types.
B Weigelt, H M Horlings, B Kreike, M M Hayes, M Hauptmann, L F A Wessels, D de Jong, M J Van de Vijver, L J Van't Veer, J L Peterse. J Pathol 2008
355
9

Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles.
F Bertucci, B Orsetti, V Nègre, P Finetti, C Rougé, J-C Ahomadegbe, F Bibeau, M-C Mathieu, I Treilleux, J Jacquemier,[...]. Oncogene 2008
86
9

Primary systemic chemotherapy of invasive lobular carcinoma of the breast.
Artur Katz, Everardo D Saad, Peggy Porter, Lajos Pusztai. Lancet Oncol 2007
73
10

Classical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristics.
Jing Yu, David J Dabbs, Yongli Shuai, Leo A Niemeier, Rohit Bhargava. Am J Clin Pathol 2011
27
29

Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
Lucio Fortunato, Alessandra Mascaro, Igor Poccia, Renato Andrich, Mostafà Amini, Leopoldo Costarelli, Giuliana Cortese, Massimo Farina, Carlo Vitelli. Ann Surg Oncol 2012
45
17

Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
David J Dabbs, Stuart J Schnitt, Felipe C Geyer, Britta Weigelt, Frederick L Baehner, Thomas Decker, Vincenzo Eusebi, Stephen B Fox, Shu Ichihara, Sunil R Lakhani,[...]. Am J Surg Pathol 2013
86
9

Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma.
V F Cocquyt, P N Blondeel, H T Depypere, M M Praet, V R Schelfhout, O E Silva, J Hurley, R F Serreyn, K K Daems, S J P Van Belle. Eur J Surg Oncol 2003
104
9

Is pleomorphic lobular carcinoma really a distinct clinical entity?
Claire L Buchanan, Laurie W Flynn, Melissa P Murray, Farbod Darvishian, Milicent L Cranor, Jane V Fey, Tari A King, Lee K Tan, Lisa M Sclafani. J Surg Oncol 2008
54
12

E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.
G Berx, A M Cleton-Jansen, K Strumane, W J de Leeuw, F Nollet, F van Roy, C Cornelisse. Oncogene 1996
370
8

Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.
S Droufakou, V Deshmane, R Roylance, A Hanby, I Tomlinson, I R Hart. Int J Cancer 2001
167
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.